皮皮林调节IR/Akt/GLUT4通路以减轻胰岛素抵抗:来自动物和计算研究的证据
Monisha Prasad1, Selvaraj Jayaraman1, Sathan Raj Natarajan1
1Centre of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College & Hospitals, Saveetha Institute of Medical & Technical Sciences, Saveetha University, Chennai 600077, India.
International journal of biological macromolecules
|October 5, 2023
概括
Piperine (PIP) 是一种来自胡的化合物,在治疗2型糖尿病方面表现有前途. 这项研究发现,PIP在老鼠中改善了代谢健康和胰岛素信号传递,这表明它可能是糖尿病管理的天然疗法.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 代谢研究研究 代谢研究
背景情况:
- 全球糖尿病患病率正在增加,特别是在印度.
- 药用草药显示出糖尿病管理的潜力.
- Piperine (PIP) 是胡中的生物活性化合物,具有有益的特性.
研究的目的:
- 调查皮佩林 (PIP) 是否可以缓解高脂肪饮食 (HFD) 诱导的糖尿病.
- 评估PIP对脂肪组织中与胰岛素通路相关的分子的影响.
- 为PIP作为天然糖尿病治疗方法提供体内证据.
主要方法:
- 在60天的时间里,老鼠吃了高脂肪饮食 (HFD).
- PIP (40 mg/kg) 治疗时间为一个月.
- 分析了代谢指标,抗氧化剂/碳水化合物酶和胰岛素信号 (mRNA/蛋白质).
- 用分子对接来评估PIP与关键蛋白质的结合亲和力.
主要成果:
- PIP显著改善了代谢指标,抗氧化剂和碳水化合物代谢酶.
- PIP使胰岛素信号通路的破坏的mRNA和蛋白质表达正常化.
- 分子对接显示了PIP与Akt,IR,IRS-1,GLUT4,AS160和β-arrestin强有力的结合.
- PIP显示出强大的抗脂血和抗氧化特性.
结论:
- 通过与关键的葡萄糖代谢调节蛋白相互作用,PIP有效控制血糖.
- 这项研究提供了新的体内证据,证明PIP对HFD诱导的2型糖尿病 (T2DM) 的有效性.
- 皮佩林 (PIP) 是一种潜在的天然治疗剂,可以提高糖尿病患者的生活质量,帮助疾病管理.
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.2K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.2K
Glucagon-like Receptor Agonists
337
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
337
Dipeptidyl Peptidase 4 Inhibitors
196
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
196
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.3K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.3K
Hormones Regulating Blood Glucose
3.5K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
3.5K


